| Product Code: ETC12923218 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Androgen Deprivation Therapy Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Androgen Deprivation Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Androgen Deprivation Therapy Market - Industry Life Cycle |
3.4 Japan Androgen Deprivation Therapy Market - Porter's Five Forces |
3.5 Japan Androgen Deprivation Therapy Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
3.6 Japan Androgen Deprivation Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Japan Androgen Deprivation Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Japan Androgen Deprivation Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Androgen Deprivation Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of prostate cancer in Japan |
4.2.2 Growing aging population in Japan |
4.2.3 Rising awareness about androgen deprivation therapy among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 High cost associated with androgen deprivation therapy |
4.3.2 Side effects and complications of long-term use of androgen deprivation therapy |
4.3.3 Stringent regulatory requirements for approval and marketing of androgen deprivation therapy drugs |
5 Japan Androgen Deprivation Therapy Market Trends |
6 Japan Androgen Deprivation Therapy Market, By Types |
6.1 Japan Androgen Deprivation Therapy Market, By Therapeutic Class |
6.1.1 Overview and Analysis |
6.1.2 Japan Androgen Deprivation Therapy Market Revenues & Volume, By Therapeutic Class, 2021 - 2031F |
6.1.3 Japan Androgen Deprivation Therapy Market Revenues & Volume, By LHRH Agonists, 2021 - 2031F |
6.1.4 Japan Androgen Deprivation Therapy Market Revenues & Volume, By Antiandrogens, 2021 - 2031F |
6.2 Japan Androgen Deprivation Therapy Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Japan Androgen Deprivation Therapy Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.2.3 Japan Androgen Deprivation Therapy Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.4 Japan Androgen Deprivation Therapy Market Revenues & Volume, By Transdermal, 2021 - 2031F |
6.3 Japan Androgen Deprivation Therapy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Japan Androgen Deprivation Therapy Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.4 Japan Androgen Deprivation Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Japan Androgen Deprivation Therapy Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.4.3 Japan Androgen Deprivation Therapy Market Revenues & Volume, By Online Sales, 2021 - 2031F |
7 Japan Androgen Deprivation Therapy Market Import-Export Trade Statistics |
7.1 Japan Androgen Deprivation Therapy Market Export to Major Countries |
7.2 Japan Androgen Deprivation Therapy Market Imports from Major Countries |
8 Japan Androgen Deprivation Therapy Market Key Performance Indicators |
8.1 Number of new prostate cancer cases diagnosed annually in Japan |
8.2 Percentage of urologists prescribing androgen deprivation therapy as a treatment option |
8.3 Patient adherence rate to androgen deprivation therapy treatment regimen |
8.4 Research and development investment in developing new androgen deprivation therapy drugs |
8.5 Rate of adoption of advanced technologies in administering androgen deprivation therapy |
9 Japan Androgen Deprivation Therapy Market - Opportunity Assessment |
9.1 Japan Androgen Deprivation Therapy Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
9.2 Japan Androgen Deprivation Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Japan Androgen Deprivation Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Japan Androgen Deprivation Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Androgen Deprivation Therapy Market - Competitive Landscape |
10.1 Japan Androgen Deprivation Therapy Market Revenue Share, By Companies, 2024 |
10.2 Japan Androgen Deprivation Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here